[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US NIPD Market Growth Potential Examined in New Insightful Study Now Available at MarketPublishers.com

14 Aug 2012 • by Natalie Aster

LONDON – Though being in its nascent stage of development, the non-invasive prenatal diagnostics (NIPD) segment presents a lucrative growth potential to a host of industry participants. The segment is chiefly supported by rising incidences of fetal health-related abnormalities and the urgent need for safe, accurate and early diagnosis. Products such as MaterniT21 Plus, Verifi, and Harmony prenatal tests are the current tests available in the market.

To date, the US NIPD sector is characterized by the presence of the companies that are effectively promoting their LDTs among the US population, especially targeting physicians to recommend their products. In future, the launch of Natera’s test is expected to impact the market significantly, thereby boosting the potential size and sample volume.

New research study “US Non-Invasive Prenatal Diagnostics - Market Insight” drawn up by RNCOS has been recently published by Market Publishers Ltd.

Report Details:

US Non-Invasive Prenatal Diagnostics - Market Insight
Published: August, 2012
Pages: 60
Price: US$ 1.200,00

The report provides in-depth analysis of the current and future of the US non-invasive prenatal diagnostics market. A special emphasis is placed on a thorough analysis of the present regulatory framework by illustrating the views of regulatory authorities, players and consumers towards the regulatory stringency and the direction of regulations in the future. Clinical trials in the NIPD field through an active participation of public and private players are provided to assess the research and innovation. Furthermore, the study features the competitive landscape in the US non-invasive prenatal diagnostics market as well as analyzes the top market players through an overview of their products as well as an assessment of their strengths & weaknesses.

Companies discussed include: Ariosa Diagnostics, Sequenom, Verinata, Natera, and Fluidigm.

More new market research studies by the publisher can be found at RNCOS page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]


Analytics & News

Weekly Digest